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THE INHIBITORY ACTION OF 1:2:5:6-DIBENZANTHRACENE ON
THE GROWTH OF THE WALKER CARCINOMA 256 IN RATS
MAINTAINED ON HIGH AND LOW PROTEIN DIETS.
L. A. ELSON AND A. HADDOW.
From The Chester Beatty Research Institute, The Royal Cancer
Hospital (Free), London, S.W. 3.
TH:E protein content of the diet has been shown to have a profound effect on
the inhibition of body growth of rats which is produced by 1:2:5:6-dibenzan-
thracene (Elson and Warren, 1947). If the tumour inhibiting properties of this
hydrocarbon (Haddow, 1935; Haddow and Robinson, 1937) are related to its
property ofbody growth inhibition, it seemed probable that the degree oftumour
inhibition obtained with it mnight also be directly influenced by the protein
content of the diet. Experiments to test this have now been carried out.
EXPERIMENTAL.
Inhibition of tumour growth by 1:2:5:6-dibenzanthracene in animals maintained on
20 per cent and 10 per cent protein diets.
One group of 18 male Wistar rats was maintained on a high (20 per cent)
protein diet, and another similar group of 18 animals on a low (10 per cent) protein
diet. The composition of the diets was the same as those used for the body
growth inhibition experiments (Elson and WVarren,. 1947, Table I). The animals
were kept in separate cages and weighed every 2 or 3 days. After being on the
diet for 14 days both groups were implanted with the Walker carcinoma 256, and
9 animals of each group were later the same day also given an intraperitoneal
injection of 50 mg. 1:2:5:6-dibenzanthracene in 1 c.c. arachis oil, the remaining
9 animals of each group acting as controls and receiving an injection of 1 c.c.
arachis oil alone. The weighing ofthe animals was continued during the develop-
ment of the tumours, and an index of the size of the tumours obtained after
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7 days andagain after 10 days by measuring along two axeswith calipers. Accord-
ing to these measurements very little difference was observed between the size
of the tumours of the control and dibenzanthracene treated animals in the high
protein group after 7 days, and the tumours ofthe treated animals appeared to be
only slightly smaller than those of the controls after 10 days.
In the low protein group, however, the measurements on the 7th and on the
10th days showed that there was considerable inhibition of tumour growth in
the animals treated with dibenzanthracene, while the tumours of the control
animals had grown to about the same size as those of the controls of the high
protein group. After 11 days the animals were killed and the tumours dissected
out and weighed. The weights are given in Table I. Very little tumour inhibi-
tion was obtained when the animals were maintained on the high protein diet,
the ratio of the average weight of the tumours of the control animals to the
average weight of the tumours of the dibenzanthracene treated animals (C/T)
being 1.8, whereas in the animals maintained on the low protein diet a marked
inhibition of tumour growth occurred (C/T = 40).
TABLE 1.-Action of 1:2:5:6-Dibenzanthracene on Walker Rat Carcinoma 256 in
Animals Maintained on 20 per cent and 10 per cent Protein Diets.
50 mg. Dibenzanthracene/100 g. rat. Weight of tumours after 11 days.
High (20 per cent) protein diet.
Controls. 1:2:5:6-dibenzan-
thracene treated.
10.5g. . 5.5g.
16.0g. · 13.0g.
13.5g. . 7.5g.
170g. . 7.5g.
110 g. . 3 g.-
14.0g. . 11.0g.
18.5g. . 11.0g.
190g. . 5.0g.
Il-0g. . 7 0g.
Mean 7 9 g.
T 1-8
Low (10 per cent) protein diet.
1:2:5:6-dibenzan- Controls. thracene treated.
205g. . 3.0g.
105g. . 5.0g.
14*0g. . 2.0g.
17.0g. . 6.0g.
170g. . 3.0g.
13.0g. . 40g.
18.0g. . 2.0g.
14.5 g. . 4.5g.
.. . 5.5g.
Mean 15.6g. Mean 3'9g.
C
4.0T--
By subtracting the weight of the tumour from the weight of the tumour-
bearing rat when killed, the average total gain in weight of the animal minus
tumour in the 11 days after implantation of the tumour was obtained and is
given in Table II. In considering the growth of the rat in relation to the growth
TABLE II.-Average Total Gain in Weight of Rat Minus Tumnour during Period of
Tuqmour Growth.
High (20 per cent) protein diet.
Controls. 1:2:5:6-dibenxan- thracene treated.
Low (10 per cent) protein diet.
1:2:5:6-dibenzan- Controls. thracene treated.
-62 g. . 1-8g.
Mean 14-5g.
98
4.4g. 8'6 g.GROWTH OF THE WALKER CARCINOMA 256 IN RATS
of the tumour, at first both rat and tumour increase in weight, but after a time
the tumour gains weight very rapidly and begins to grow at the expense of the
rat. This is seen particularly well in the animals on the 10 per cent protein diet,
where after 11 days the control animals have lost an average of 6.2 g., while the
tumours in these animals have gained 15.6 g. On the other hand the dibenzan-
thracene treated animals, in spite of body growth inhibition induced by this
compound on the 10 per cent protein diet, gained 1.8 g. in 11 days, while the
tumour gained 3.9 g.
Inhibition of tumour growth by 1:2:5:6-dibenzanthracene in animals maintained on
20 per cent, 10 per cent and 5 per cent protein diets.
A further tumour inhibition experiment was carried out on animals main-
tained on 20 per cent, 10 per cent and 5 per cent protein diets. The composition
of the 20 per cent and 10 per cent protein diets was the same as that used in the
previous experiment, and that of the 5 per cent diet was the same as described
in Elson, Goulden and Warren (1947-Table II). 1:2:5:6-Dibenzanthracene
(50 mg. per rat in 1 c.c. arachis oil) was administered by intraperitoneal injection
to half the animals in each group, in this case 24 hours after they had received
the tumour implantation, the control animals receiving at the same time 1 c.c.
ofarachis oil alone. The tumours were allowed to grow for 13 days after implan-
tation, and the rats then killed and the tumours dissected out and weighed.
The weights are given in Table III. Again on the 20 per cent protein diet very
TABLE III.-Action of 1:2:5:6-Dibenzanthracene on Walker Rat Carcinoma 256 in
Animals Maintained on 20 per cent, 10 per cent and 5 per cent Protein Diets.
50 mg. Dibenzanthracene/100 g. rat. Weight of tumours after 13 days.
20 per cent prot
1:2:5:6-d Controls. 1:2:5:6-d
thracenE
22'5 1
23*2 9
18'4 8
9'0 6
18'2 8
15'6 8
11'3 13
8'9 2
20'0
5.3
ein diet. 10 per cent protein diet.
ibenzan- Controls. 1:2:5:6-dibenzan-
e treated. Controls. thracene treated.
L6 1 . 14.1 11-0
!'5 . 12'6 3 0
;'6 . 27'4 14.4
'2 . 24'4 9'4
;'3 . 27 1 14'7
;'6 . 20-5 6'3
'0( . 24'7 5.0
.'7 . 13'0 6'0
.. . 20'0 7'8
... .. 7'72
5 per cent protein diet.
1:2:5:6-dibenzan- Controls. thracene treated.
16'6 1 6
22'9 6'S
6"0 3 4
14'4 5'6
21'1 2'3
13'3 5'8
23'0 7'5
17'8 1.8
9 3 4.5
15*8 2*0
Mean 15 2 9.2 Mean 20-4
CT-- 1.6 T
8.4
C
T = 2-5
Mean 16.0 4.1
C =4.0
little tumour inhibition was obtained with dibenzanthracene (C/T = 1.6), definite
tumour inhibition was obtained on the 10 per cent protein diet (C/T = 2.5), and
marked tumour inhibition on the 5 per cent protein diet (C/T 4.0). The
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average total gain in weight of the animals minus tumours in the 13 days after
implantation of the tumours is given in Table 1V.
TABLE IV.-Average Total Gain in Weight of Rat Minus Tumour during Period of
Tumnour Growth.
20 per cent protein diet. 10 per cent protein diet. 5 per cent protein diet.
.1- .......................
Controls. 1:2:5:6-dibenzan- Controls 1:2:5:6-dibenzan- Controls 1:2:5:6-dibenzan-
thracene treated. thracene treated. thracene treated.
7.9g. 12.6g. . -13-9g. 4.5g. . -13.6g. -0 1 g.
DISCUSSION.
The mechanism of the tumour inhibitory action of 1:2:5:6-dibenzanthra-
cene appears to be essentially the same as that of its body growth inhibition.
Both are influenced to a very large extent by the protein content of the diet,
and it is suggested that the inhibition is caused by an interference with the
availability, or with the actual synthesis, ofprotein necessary for cellular growth.
With a dose of 50 mg./100 g. of 1:2:5:6-dibenzanthracene complete
growth inhibition fcr a long period can be obtained in animals maintained on
10 per cent and 5 per cent protein diets. It is not, however, possible to inhibit
the growth of the WValker carcinoma 256 completely in these animals, although a
very considerable slowing down ofthe growth rate ofthe tumour can be obtained.
In the early stages oftumour growth both animal and tumour increase in weight,
but the tumour gains rapidly and eventually the body weight decreases while the
tumour continues to gain. The inhibitor, by slowing the growth of the animal
and of the tumour, extends the time required for the latter to reach such pro-
portions that its growth at the expense of the body tissues becomes a major
factor. The effect is thus most marked during the early growth of the tumour.
It is highly probable, therefore, that complete control of tumour growth is
not attainable with an inhibitor of this type, and could only be achieved by a
substance having a more specific action on tumour cells. There is no evidence
that 1:2:5:6-dibenzanthracene has any such specific action.
Apreliminaryexamination of2'-chloro-4-dimethylaminostilbene, one ofaseries
ofvery powerful tumourinhibiting compounds discovered by Haddow, Harris and
Kon (1945), reveals that its action is also almost entirely dependent on the
protein content of the diet. On a 20 per cent protein diet no inhibiting effect
of the compound on the growth of the Walker carcinoma 256 was observed
wt. of tumours of control animals 1. ) whereas on a 5 per cent protein diet wt. oftumours of treated animals TC,
a very remarkable inhibition oftumnour growth was obtained (C-190), although
the tumours grew equally well in the control animals mraintained on the 5 per
cent or the 20 per cent protein diet. Moreover, while 1:2:5:6-dibenzan-
thracene appears to have a relatively greater inhibiting effect on the growth
of the animal than on the growth of the tumour, the reverse is the case with the
stilbene derivative. Preliminary evidence thus indicates that the growth
inhibition shown by this latter type of compound may be associated with a more
specific effect on the synthesis of proteins required by the tumour cell.
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Some tentative idea of the nature of the inhibiting action of carcinogens such
as 1:2:5:6-dibenzanthracene on the growth of cells may be deduced from the
present result considered in conjunction with work on the inhibition of enzyme
systems by metabolic products of carcinogenic azo compounds, and on the
metabolism of aromatic amines. It is very probable that aromatic compounds
of this type combine with sulphydryl-contairiing substances at an early stage in
their metabolism. This is then followed by oxidation, and the substance is
normally finally excreted as an ethereal sulphate. In the case ofthe carcinogenic
and tumour inhibiting amine 4-aminostilbene it has been found that this elimina-
tion mechanism apparently breaks down at some stage, and instead of the com-
pound being eliminated as an ethereal sulphate, free 4-amino-4'-hydroxystilbene
is formed, part ofwhich is then excreted conjugated with glucuronic acid (Elson,
Goulden and Warren, 1946). Free amino hydroxy compounds of this type are
capable of being oxidized in vivo by enzymes such as cytochrome oxidase to
quinonoid derivatives which are powerfill inhibitors of a large number of enzyme
systems, particularly those dependent on free sulphydryl groups for their activity
(Elson and Hoch-Ligeti, 1946; Elson, 1947). The formation from 1:2:5:6-
dibenzanthracene of similar products toxic to enzymes may well be a factor
in its interference with processes of protein metabolism and synthesis.
Since, according to the work of Caspersson and others (Caspersson and
Santesson, 1942), protein synthesis is associated with high concentrations of
nucleic acids in the cell, and the nucleic acid concentration is intimately connected
with cell division, the probable inhibition of protein synthesis by 1:2:5:6-
dibenzanthracene suggests consequences in the disturbance of nucleoprotein
metabolism which may be directly connected with the process of carcinogenesis.
SUMMARY.
The inhibiting action of 1:2:5:6-dibenzanthracene on the growth of the
Walker rat carcinoma 256 has been found to be dependent on the protein content
of the diet. With animals maintained on a 20 per cent protein diet very little
growth inhibitory action is observed, on a 10 per cent protein diet moderate
inhibition, and on a 5 per cent protein diet marked inhibition of tumour growth
can be obtained.
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